• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.48% Nasdaq Up 0.28%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    71.01 Down 0.56(0.78%) Jan 20, 4:00PM EST
    Prev Close:71.57
    Open:71.97
    Bid:70.99 x 5500
    Ask:71.11 x 1000
    1y Target Est:95.01
    Beta:0.882113
    Next Earnings Date: 7-Feb-17GILD Earnings announcement
    Day's Range:70.58 - 72.00
    52wk Range:70.58 - 103.10
    Volume:10,270,332
    Avg Vol (3m):9,755,930
    Market Cap:93.55B
    P/E (ttm):6.57
    EPS (ttm):10.82
    Div & Yield:1.88 (2.61%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.78%93.55B
    GSKDown 0.08%96.46B
    PFEUp 0.22%192.79B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):6.62
    P/S (ttm):2,986.14
    Ex-Dividend Date:13-Dec-16

    Analysts

    Annual EPS Est (Dec-16) :11.45
    Quarterly EPS Est (Dec-16) :2.61
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-2.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback